nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitaxentan—Leukopenia—Vincristine—muscle cancer	0.00176	0.00176	CcSEcCtD
Sitaxentan—Thrombocytopenia—Dactinomycin—muscle cancer	0.00176	0.00176	CcSEcCtD
Sitaxentan—Dry eye—Doxorubicin—muscle cancer	0.00175	0.00175	CcSEcCtD
Sitaxentan—Anorexia—Dactinomycin—muscle cancer	0.00171	0.00171	CcSEcCtD
Sitaxentan—Eye disorder—Etoposide—muscle cancer	0.00171	0.00171	CcSEcCtD
Sitaxentan—Neoplasm—Doxorubicin—muscle cancer	0.00171	0.00171	CcSEcCtD
Sitaxentan—Flushing—Etoposide—muscle cancer	0.0017	0.0017	CcSEcCtD
Sitaxentan—Cardiac disorder—Etoposide—muscle cancer	0.0017	0.0017	CcSEcCtD
Sitaxentan—Visual disturbance—Methotrexate—muscle cancer	0.00167	0.00167	CcSEcCtD
Sitaxentan—Angiopathy—Etoposide—muscle cancer	0.00166	0.00166	CcSEcCtD
Sitaxentan—Immune system disorder—Etoposide—muscle cancer	0.00166	0.00166	CcSEcCtD
Sitaxentan—Mediastinal disorder—Etoposide—muscle cancer	0.00165	0.00165	CcSEcCtD
Sitaxentan—Mental disability—Doxorubicin—muscle cancer	0.00164	0.00164	CcSEcCtD
Sitaxentan—Alopecia—Etoposide—muscle cancer	0.00162	0.00162	CcSEcCtD
Sitaxentan—Oedema—Vincristine—muscle cancer	0.00161	0.00161	CcSEcCtD
Sitaxentan—Infection—Vincristine—muscle cancer	0.0016	0.0016	CcSEcCtD
Sitaxentan—Osteoarthritis—Methotrexate—muscle cancer	0.00159	0.00159	CcSEcCtD
Sitaxentan—Nervous system disorder—Vincristine—muscle cancer	0.00158	0.00158	CcSEcCtD
Sitaxentan—Thrombocytopenia—Vincristine—muscle cancer	0.00157	0.00157	CcSEcCtD
Sitaxentan—Decreased appetite—Dactinomycin—muscle cancer	0.00156	0.00156	CcSEcCtD
Sitaxentan—Fatigue—Dactinomycin—muscle cancer	0.00155	0.00155	CcSEcCtD
Sitaxentan—Pain—Dactinomycin—muscle cancer	0.00154	0.00154	CcSEcCtD
Sitaxentan—Muscle spasms—Etoposide—muscle cancer	0.00153	0.00153	CcSEcCtD
Sitaxentan—Anorexia—Vincristine—muscle cancer	0.00153	0.00153	CcSEcCtD
Sitaxentan—Hepatic failure—Doxorubicin—muscle cancer	0.00153	0.00153	CcSEcCtD
Sitaxentan—Cardiac failure congestive—Doxorubicin—muscle cancer	0.00151	0.00151	CcSEcCtD
Sitaxentan—Hypotension—Vincristine—muscle cancer	0.0015	0.0015	CcSEcCtD
Sitaxentan—Ataxia—Methotrexate—muscle cancer	0.00149	0.00149	CcSEcCtD
Sitaxentan—Feeling abnormal—Dactinomycin—muscle cancer	0.00148	0.00148	CcSEcCtD
Sitaxentan—Ill-defined disorder—Etoposide—muscle cancer	0.00148	0.00148	CcSEcCtD
Sitaxentan—Anaemia—Etoposide—muscle cancer	0.00147	0.00147	CcSEcCtD
Sitaxentan—Liver function test abnormal—Methotrexate—muscle cancer	0.00146	0.00146	CcSEcCtD
Sitaxentan—Increased appetite—Doxorubicin—muscle cancer	0.00146	0.00146	CcSEcCtD
Sitaxentan—Menopausal symptoms—Doxorubicin—muscle cancer	0.00146	0.00146	CcSEcCtD
Sitaxentan—Insomnia—Vincristine—muscle cancer	0.00145	0.00145	CcSEcCtD
Sitaxentan—Renal impairment—Doxorubicin—muscle cancer	0.00144	0.00144	CcSEcCtD
Sitaxentan—Malaise—Etoposide—muscle cancer	0.00144	0.00144	CcSEcCtD
Sitaxentan—Breast disorder—Methotrexate—muscle cancer	0.00143	0.00143	CcSEcCtD
Sitaxentan—Vertigo—Etoposide—muscle cancer	0.00143	0.00143	CcSEcCtD
Sitaxentan—Leukopenia—Etoposide—muscle cancer	0.00143	0.00143	CcSEcCtD
Sitaxentan—Body temperature increased—Dactinomycin—muscle cancer	0.00142	0.00142	CcSEcCtD
Sitaxentan—Hypoglycaemia—Doxorubicin—muscle cancer	0.00141	0.00141	CcSEcCtD
Sitaxentan—Cardiac failure—Doxorubicin—muscle cancer	0.00141	0.00141	CcSEcCtD
Sitaxentan—Decreased appetite—Vincristine—muscle cancer	0.0014	0.0014	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Vincristine—muscle cancer	0.00139	0.00139	CcSEcCtD
Sitaxentan—Fatigue—Vincristine—muscle cancer	0.00139	0.00139	CcSEcCtD
Sitaxentan—Pain—Vincristine—muscle cancer	0.00137	0.00137	CcSEcCtD
Sitaxentan—Constipation—Vincristine—muscle cancer	0.00137	0.00137	CcSEcCtD
Sitaxentan—Osteoarthritis—Doxorubicin—muscle cancer	0.00137	0.00137	CcSEcCtD
Sitaxentan—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.00137	0.00137	CcSEcCtD
Sitaxentan—Asthma—Methotrexate—muscle cancer	0.00137	0.00137	CcSEcCtD
Sitaxentan—Chest pain—Etoposide—muscle cancer	0.00136	0.00136	CcSEcCtD
Sitaxentan—Eosinophilia—Methotrexate—muscle cancer	0.00136	0.00136	CcSEcCtD
Sitaxentan—Migraine—Doxorubicin—muscle cancer	0.00135	0.00135	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00135	0.00135	CcSEcCtD
Sitaxentan—Discomfort—Etoposide—muscle cancer	0.00134	0.00134	CcSEcCtD
Sitaxentan—Hypersensitivity—Dactinomycin—muscle cancer	0.00133	0.00133	CcSEcCtD
Sitaxentan—Abdominal discomfort—Methotrexate—muscle cancer	0.00131	0.00131	CcSEcCtD
Sitaxentan—Confusional state—Etoposide—muscle cancer	0.00131	0.00131	CcSEcCtD
Sitaxentan—Pancytopenia—Methotrexate—muscle cancer	0.0013	0.0013	CcSEcCtD
Sitaxentan—Infection—Etoposide—muscle cancer	0.00129	0.00129	CcSEcCtD
Sitaxentan—Ataxia—Doxorubicin—muscle cancer	0.00129	0.00129	CcSEcCtD
Sitaxentan—Asthenia—Dactinomycin—muscle cancer	0.00129	0.00129	CcSEcCtD
Sitaxentan—Blood creatinine increased—Doxorubicin—muscle cancer	0.00129	0.00129	CcSEcCtD
Sitaxentan—Dysuria—Methotrexate—muscle cancer	0.00128	0.00128	CcSEcCtD
Sitaxentan—Dehydration—Doxorubicin—muscle cancer	0.00128	0.00128	CcSEcCtD
Sitaxentan—Thrombocytopenia—Etoposide—muscle cancer	0.00127	0.00127	CcSEcCtD
Sitaxentan—Tachycardia—Etoposide—muscle cancer	0.00127	0.00127	CcSEcCtD
Sitaxentan—Body temperature increased—Vincristine—muscle cancer	0.00127	0.00127	CcSEcCtD
Sitaxentan—Liver function test abnormal—Doxorubicin—muscle cancer	0.00127	0.00127	CcSEcCtD
Sitaxentan—Skin disorder—Etoposide—muscle cancer	0.00126	0.00126	CcSEcCtD
Sitaxentan—Dry skin—Doxorubicin—muscle cancer	0.00126	0.00126	CcSEcCtD
Sitaxentan—Orthostatic hypotension—Doxorubicin—muscle cancer	0.00125	0.00125	CcSEcCtD
Sitaxentan—Abdominal pain upper—Doxorubicin—muscle cancer	0.00125	0.00125	CcSEcCtD
Sitaxentan—Photosensitivity reaction—Methotrexate—muscle cancer	0.00125	0.00125	CcSEcCtD
Sitaxentan—Breast disorder—Doxorubicin—muscle cancer	0.00124	0.00124	CcSEcCtD
Sitaxentan—Anorexia—Etoposide—muscle cancer	0.00124	0.00124	CcSEcCtD
Sitaxentan—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.00124	0.00124	CcSEcCtD
Sitaxentan—Diarrhoea—Dactinomycin—muscle cancer	0.00123	0.00123	CcSEcCtD
Sitaxentan—Infestation NOS—Methotrexate—muscle cancer	0.00122	0.00122	CcSEcCtD
Sitaxentan—Infestation—Methotrexate—muscle cancer	0.00122	0.00122	CcSEcCtD
Sitaxentan—Hypotension—Etoposide—muscle cancer	0.00122	0.00122	CcSEcCtD
Sitaxentan—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00121	0.00121	CcSEcCtD
Sitaxentan—Muscular weakness—Doxorubicin—muscle cancer	0.00121	0.00121	CcSEcCtD
Sitaxentan—Renal failure—Methotrexate—muscle cancer	0.0012	0.0012	CcSEcCtD
Sitaxentan—Stomatitis—Methotrexate—muscle cancer	0.00119	0.00119	CcSEcCtD
Sitaxentan—Conjunctivitis—Methotrexate—muscle cancer	0.00119	0.00119	CcSEcCtD
Sitaxentan—Asthma—Doxorubicin—muscle cancer	0.00119	0.00119	CcSEcCtD
Sitaxentan—Hypersensitivity—Vincristine—muscle cancer	0.00118	0.00118	CcSEcCtD
Sitaxentan—Eosinophilia—Doxorubicin—muscle cancer	0.00118	0.00118	CcSEcCtD
Sitaxentan—Haematuria—Methotrexate—muscle cancer	0.00117	0.00117	CcSEcCtD
Sitaxentan—Somnolence—Etoposide—muscle cancer	0.00116	0.00116	CcSEcCtD
Sitaxentan—Angina pectoris—Doxorubicin—muscle cancer	0.00116	0.00116	CcSEcCtD
Sitaxentan—Hepatobiliary disease—Methotrexate—muscle cancer	0.00116	0.00116	CcSEcCtD
Sitaxentan—Epistaxis—Methotrexate—muscle cancer	0.00115	0.00115	CcSEcCtD
Sitaxentan—Asthenia—Vincristine—muscle cancer	0.00115	0.00115	CcSEcCtD
Sitaxentan—Vomiting—Dactinomycin—muscle cancer	0.00114	0.00114	CcSEcCtD
Sitaxentan—Bronchitis—Doxorubicin—muscle cancer	0.00114	0.00114	CcSEcCtD
Sitaxentan—Rash—Dactinomycin—muscle cancer	0.00113	0.00113	CcSEcCtD
Sitaxentan—Decreased appetite—Etoposide—muscle cancer	0.00113	0.00113	CcSEcCtD
Sitaxentan—Pancytopenia—Doxorubicin—muscle cancer	0.00113	0.00113	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Etoposide—muscle cancer	0.00112	0.00112	CcSEcCtD
Sitaxentan—Fatigue—Etoposide—muscle cancer	0.00112	0.00112	CcSEcCtD
Sitaxentan—Pain—Etoposide—muscle cancer	0.00111	0.00111	CcSEcCtD
Sitaxentan—Constipation—Etoposide—muscle cancer	0.00111	0.00111	CcSEcCtD
Sitaxentan—Dysuria—Doxorubicin—muscle cancer	0.00111	0.00111	CcSEcCtD
Sitaxentan—Haemoglobin—Methotrexate—muscle cancer	0.0011	0.0011	CcSEcCtD
Sitaxentan—Diarrhoea—Vincristine—muscle cancer	0.0011	0.0011	CcSEcCtD
Sitaxentan—Haemorrhage—Methotrexate—muscle cancer	0.0011	0.0011	CcSEcCtD
Sitaxentan—Hepatitis—Methotrexate—muscle cancer	0.0011	0.0011	CcSEcCtD
Sitaxentan—Pollakiuria—Doxorubicin—muscle cancer	0.0011	0.0011	CcSEcCtD
Sitaxentan—Urinary tract disorder—Methotrexate—muscle cancer	0.00108	0.00108	CcSEcCtD
Sitaxentan—Photosensitivity reaction—Doxorubicin—muscle cancer	0.00108	0.00108	CcSEcCtD
Sitaxentan—Urethral disorder—Methotrexate—muscle cancer	0.00108	0.00108	CcSEcCtD
Sitaxentan—Weight decreased—Doxorubicin—muscle cancer	0.00107	0.00107	CcSEcCtD
Sitaxentan—Feeling abnormal—Etoposide—muscle cancer	0.00107	0.00107	CcSEcCtD
Sitaxentan—Hyperglycaemia—Doxorubicin—muscle cancer	0.00107	0.00107	CcSEcCtD
Sitaxentan—Nausea—Dactinomycin—muscle cancer	0.00107	0.00107	CcSEcCtD
Sitaxentan—Dizziness—Vincristine—muscle cancer	0.00106	0.00106	CcSEcCtD
Sitaxentan—Infestation—Doxorubicin—muscle cancer	0.00106	0.00106	CcSEcCtD
Sitaxentan—Infestation NOS—Doxorubicin—muscle cancer	0.00106	0.00106	CcSEcCtD
Sitaxentan—Visual impairment—Methotrexate—muscle cancer	0.00106	0.00106	CcSEcCtD
Sitaxentan—Renal failure—Doxorubicin—muscle cancer	0.00104	0.00104	CcSEcCtD
Sitaxentan—Urticaria—Etoposide—muscle cancer	0.00103	0.00103	CcSEcCtD
Sitaxentan—Stomatitis—Doxorubicin—muscle cancer	0.00103	0.00103	CcSEcCtD
Sitaxentan—Jaundice—Doxorubicin—muscle cancer	0.00103	0.00103	CcSEcCtD
Sitaxentan—Body temperature increased—Etoposide—muscle cancer	0.00103	0.00103	CcSEcCtD
Sitaxentan—Conjunctivitis—Doxorubicin—muscle cancer	0.00103	0.00103	CcSEcCtD
Sitaxentan—Eye disorder—Methotrexate—muscle cancer	0.00103	0.00103	CcSEcCtD
Sitaxentan—Tinnitus—Methotrexate—muscle cancer	0.00102	0.00102	CcSEcCtD
Sitaxentan—Vomiting—Vincristine—muscle cancer	0.00102	0.00102	CcSEcCtD
Sitaxentan—Cardiac disorder—Methotrexate—muscle cancer	0.00102	0.00102	CcSEcCtD
Sitaxentan—Rash—Vincristine—muscle cancer	0.00101	0.00101	CcSEcCtD
Sitaxentan—Dermatitis—Vincristine—muscle cancer	0.00101	0.00101	CcSEcCtD
Sitaxentan—Haematuria—Doxorubicin—muscle cancer	0.00101	0.00101	CcSEcCtD
Sitaxentan—Headache—Vincristine—muscle cancer	0.00101	0.00101	CcSEcCtD
Sitaxentan—Hepatobiliary disease—Doxorubicin—muscle cancer	0.001	0.001	CcSEcCtD
Sitaxentan—Epistaxis—Doxorubicin—muscle cancer	0.000999	0.000999	CcSEcCtD
Sitaxentan—Angiopathy—Methotrexate—muscle cancer	0.000996	0.000996	CcSEcCtD
Sitaxentan—Sinusitis—Doxorubicin—muscle cancer	0.000993	0.000993	CcSEcCtD
Sitaxentan—Immune system disorder—Methotrexate—muscle cancer	0.000991	0.000991	CcSEcCtD
Sitaxentan—Mediastinal disorder—Methotrexate—muscle cancer	0.000989	0.000989	CcSEcCtD
Sitaxentan—Alopecia—Methotrexate—muscle cancer	0.00097	0.00097	CcSEcCtD
Sitaxentan—Bradycardia—Doxorubicin—muscle cancer	0.000968	0.000968	CcSEcCtD
Sitaxentan—Mental disorder—Methotrexate—muscle cancer	0.000962	0.000962	CcSEcCtD
Sitaxentan—Hypersensitivity—Etoposide—muscle cancer	0.000959	0.000959	CcSEcCtD
Sitaxentan—Malnutrition—Methotrexate—muscle cancer	0.000956	0.000956	CcSEcCtD
Sitaxentan—Haemoglobin—Doxorubicin—muscle cancer	0.000955	0.000955	CcSEcCtD
Sitaxentan—Nausea—Vincristine—muscle cancer	0.000955	0.000955	CcSEcCtD
Sitaxentan—Rhinitis—Doxorubicin—muscle cancer	0.000953	0.000953	CcSEcCtD
Sitaxentan—Hepatitis—Doxorubicin—muscle cancer	0.00095	0.00095	CcSEcCtD
Sitaxentan—Haemorrhage—Doxorubicin—muscle cancer	0.00095	0.00095	CcSEcCtD
Sitaxentan—Urinary tract disorder—Doxorubicin—muscle cancer	0.000939	0.000939	CcSEcCtD
Sitaxentan—Oedema peripheral—Doxorubicin—muscle cancer	0.000936	0.000936	CcSEcCtD
Sitaxentan—Asthenia—Etoposide—muscle cancer	0.000934	0.000934	CcSEcCtD
Sitaxentan—Urethral disorder—Doxorubicin—muscle cancer	0.000932	0.000932	CcSEcCtD
Sitaxentan—Visual impairment—Doxorubicin—muscle cancer	0.000916	0.000916	CcSEcCtD
Sitaxentan—Diarrhoea—Etoposide—muscle cancer	0.000891	0.000891	CcSEcCtD
Sitaxentan—Eye disorder—Doxorubicin—muscle cancer	0.000888	0.000888	CcSEcCtD
Sitaxentan—Ill-defined disorder—Methotrexate—muscle cancer	0.000887	0.000887	CcSEcCtD
Sitaxentan—Tinnitus—Doxorubicin—muscle cancer	0.000886	0.000886	CcSEcCtD
Sitaxentan—Anaemia—Methotrexate—muscle cancer	0.000883	0.000883	CcSEcCtD
Sitaxentan—Flushing—Doxorubicin—muscle cancer	0.000882	0.000882	CcSEcCtD
Sitaxentan—Cardiac disorder—Doxorubicin—muscle cancer	0.000882	0.000882	CcSEcCtD
Sitaxentan—Angiopathy—Doxorubicin—muscle cancer	0.000862	0.000862	CcSEcCtD
Sitaxentan—Malaise—Methotrexate—muscle cancer	0.000862	0.000862	CcSEcCtD
Sitaxentan—Dizziness—Etoposide—muscle cancer	0.000861	0.000861	CcSEcCtD
Sitaxentan—Immune system disorder—Doxorubicin—muscle cancer	0.000858	0.000858	CcSEcCtD
Sitaxentan—Vertigo—Methotrexate—muscle cancer	0.000858	0.000858	CcSEcCtD
Sitaxentan—Mediastinal disorder—Doxorubicin—muscle cancer	0.000857	0.000857	CcSEcCtD
Sitaxentan—Leukopenia—Methotrexate—muscle cancer	0.000855	0.000855	CcSEcCtD
Sitaxentan—Alopecia—Doxorubicin—muscle cancer	0.00084	0.00084	CcSEcCtD
Sitaxentan—Mental disorder—Doxorubicin—muscle cancer	0.000833	0.000833	CcSEcCtD
Sitaxentan—Vomiting—Etoposide—muscle cancer	0.000828	0.000828	CcSEcCtD
Sitaxentan—Malnutrition—Doxorubicin—muscle cancer	0.000827	0.000827	CcSEcCtD
Sitaxentan—Rash—Etoposide—muscle cancer	0.000821	0.000821	CcSEcCtD
Sitaxentan—Dermatitis—Etoposide—muscle cancer	0.00082	0.00082	CcSEcCtD
Sitaxentan—Headache—Etoposide—muscle cancer	0.000816	0.000816	CcSEcCtD
Sitaxentan—Chest pain—Methotrexate—muscle cancer	0.000813	0.000813	CcSEcCtD
Sitaxentan—Tension—Doxorubicin—muscle cancer	0.000812	0.000812	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000808	0.000808	CcSEcCtD
Sitaxentan—Discomfort—Methotrexate—muscle cancer	0.000804	0.000804	CcSEcCtD
Sitaxentan—Nervousness—Doxorubicin—muscle cancer	0.000804	0.000804	CcSEcCtD
Sitaxentan—Muscle spasms—Doxorubicin—muscle cancer	0.000795	0.000795	CcSEcCtD
Sitaxentan—Confusional state—Methotrexate—muscle cancer	0.000786	0.000786	CcSEcCtD
Sitaxentan—Infection—Methotrexate—muscle cancer	0.000775	0.000775	CcSEcCtD
Sitaxentan—Nausea—Etoposide—muscle cancer	0.000773	0.000773	CcSEcCtD
Sitaxentan—Ill-defined disorder—Doxorubicin—muscle cancer	0.000768	0.000768	CcSEcCtD
Sitaxentan—Nervous system disorder—Methotrexate—muscle cancer	0.000765	0.000765	CcSEcCtD
Sitaxentan—Anaemia—Doxorubicin—muscle cancer	0.000765	0.000765	CcSEcCtD
Sitaxentan—Thrombocytopenia—Methotrexate—muscle cancer	0.000764	0.000764	CcSEcCtD
Sitaxentan—Agitation—Doxorubicin—muscle cancer	0.00076	0.00076	CcSEcCtD
Sitaxentan—Skin disorder—Methotrexate—muscle cancer	0.000757	0.000757	CcSEcCtD
Sitaxentan—Malaise—Doxorubicin—muscle cancer	0.000746	0.000746	CcSEcCtD
Sitaxentan—Vertigo—Doxorubicin—muscle cancer	0.000743	0.000743	CcSEcCtD
Sitaxentan—Anorexia—Methotrexate—muscle cancer	0.000743	0.000743	CcSEcCtD
Sitaxentan—Leukopenia—Doxorubicin—muscle cancer	0.000741	0.000741	CcSEcCtD
Sitaxentan—Hypotension—Methotrexate—muscle cancer	0.000729	0.000729	CcSEcCtD
Sitaxentan—Insomnia—Methotrexate—muscle cancer	0.000705	0.000705	CcSEcCtD
Sitaxentan—Chest pain—Doxorubicin—muscle cancer	0.000704	0.000704	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.0007	0.0007	CcSEcCtD
Sitaxentan—Discomfort—Doxorubicin—muscle cancer	0.000696	0.000696	CcSEcCtD
Sitaxentan—Somnolence—Methotrexate—muscle cancer	0.000693	0.000693	CcSEcCtD
Sitaxentan—Dry mouth—Doxorubicin—muscle cancer	0.000689	0.000689	CcSEcCtD
Sitaxentan—Dyspepsia—Methotrexate—muscle cancer	0.000686	0.000686	CcSEcCtD
Sitaxentan—Confusional state—Doxorubicin—muscle cancer	0.000681	0.000681	CcSEcCtD
Sitaxentan—Decreased appetite—Methotrexate—muscle cancer	0.000678	0.000678	CcSEcCtD
Sitaxentan—Oedema—Doxorubicin—muscle cancer	0.000675	0.000675	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000673	0.000673	CcSEcCtD
Sitaxentan—Fatigue—Methotrexate—muscle cancer	0.000672	0.000672	CcSEcCtD
Sitaxentan—Infection—Doxorubicin—muscle cancer	0.000671	0.000671	CcSEcCtD
Sitaxentan—Pain—Methotrexate—muscle cancer	0.000667	0.000667	CcSEcCtD
Sitaxentan—Nervous system disorder—Doxorubicin—muscle cancer	0.000662	0.000662	CcSEcCtD
Sitaxentan—Thrombocytopenia—Doxorubicin—muscle cancer	0.000661	0.000661	CcSEcCtD
Sitaxentan—Tachycardia—Doxorubicin—muscle cancer	0.000659	0.000659	CcSEcCtD
Sitaxentan—Skin disorder—Doxorubicin—muscle cancer	0.000656	0.000656	CcSEcCtD
Sitaxentan—Anorexia—Doxorubicin—muscle cancer	0.000644	0.000644	CcSEcCtD
Sitaxentan—Feeling abnormal—Methotrexate—muscle cancer	0.000643	0.000643	CcSEcCtD
Sitaxentan—Hypotension—Doxorubicin—muscle cancer	0.000631	0.000631	CcSEcCtD
Sitaxentan—Urticaria—Methotrexate—muscle cancer	0.00062	0.00062	CcSEcCtD
Sitaxentan—Body temperature increased—Methotrexate—muscle cancer	0.000616	0.000616	CcSEcCtD
Sitaxentan—Insomnia—Doxorubicin—muscle cancer	0.000611	0.000611	CcSEcCtD
Sitaxentan—Somnolence—Doxorubicin—muscle cancer	0.0006	0.0006	CcSEcCtD
Sitaxentan—Dyspepsia—Doxorubicin—muscle cancer	0.000594	0.000594	CcSEcCtD
Sitaxentan—Decreased appetite—Doxorubicin—muscle cancer	0.000587	0.000587	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000583	0.000583	CcSEcCtD
Sitaxentan—Fatigue—Doxorubicin—muscle cancer	0.000582	0.000582	CcSEcCtD
Sitaxentan—Constipation—Doxorubicin—muscle cancer	0.000577	0.000577	CcSEcCtD
Sitaxentan—Pain—Doxorubicin—muscle cancer	0.000577	0.000577	CcSEcCtD
Sitaxentan—Hypersensitivity—Methotrexate—muscle cancer	0.000575	0.000575	CcSEcCtD
Sitaxentan—Asthenia—Methotrexate—muscle cancer	0.00056	0.00056	CcSEcCtD
Sitaxentan—Feeling abnormal—Doxorubicin—muscle cancer	0.000556	0.000556	CcSEcCtD
Sitaxentan—Urticaria—Doxorubicin—muscle cancer	0.000536	0.000536	CcSEcCtD
Sitaxentan—Body temperature increased—Doxorubicin—muscle cancer	0.000534	0.000534	CcSEcCtD
Sitaxentan—Diarrhoea—Methotrexate—muscle cancer	0.000534	0.000534	CcSEcCtD
Sitaxentan—Dizziness—Methotrexate—muscle cancer	0.000516	0.000516	CcSEcCtD
Sitaxentan—Hypersensitivity—Doxorubicin—muscle cancer	0.000498	0.000498	CcSEcCtD
Sitaxentan—Vomiting—Methotrexate—muscle cancer	0.000496	0.000496	CcSEcCtD
Sitaxentan—Rash—Methotrexate—muscle cancer	0.000492	0.000492	CcSEcCtD
Sitaxentan—Dermatitis—Methotrexate—muscle cancer	0.000491	0.000491	CcSEcCtD
Sitaxentan—Headache—Methotrexate—muscle cancer	0.000489	0.000489	CcSEcCtD
Sitaxentan—Asthenia—Doxorubicin—muscle cancer	0.000484	0.000484	CcSEcCtD
Sitaxentan—Nausea—Methotrexate—muscle cancer	0.000463	0.000463	CcSEcCtD
Sitaxentan—Diarrhoea—Doxorubicin—muscle cancer	0.000462	0.000462	CcSEcCtD
Sitaxentan—Dizziness—Doxorubicin—muscle cancer	0.000447	0.000447	CcSEcCtD
Sitaxentan—Vomiting—Doxorubicin—muscle cancer	0.000429	0.000429	CcSEcCtD
Sitaxentan—Rash—Doxorubicin—muscle cancer	0.000426	0.000426	CcSEcCtD
Sitaxentan—Dermatitis—Doxorubicin—muscle cancer	0.000425	0.000425	CcSEcCtD
Sitaxentan—Headache—Doxorubicin—muscle cancer	0.000423	0.000423	CcSEcCtD
Sitaxentan—Nausea—Doxorubicin—muscle cancer	0.000401	0.000401	CcSEcCtD
